Handheld ultrasound could spot hidden graft failures during bypass surgery

NCT ID NCT07700524

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial tests whether using a portable ultrasound device during coronary artery bypass surgery can improve outcomes by letting surgeons see blood flow through the new grafts in real time. About 380 adults scheduled for elective bypass surgery will be randomly assigned to either standard care or standard care plus ultrasound monitoring. The study will compare rates of major complications like heart attack, stroke, kidney failure, and death, as well as how often ultrasound detects graft problems that need fixing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intraoperative portable Doppler ultrasound
What this could lead to
If successful, this approach could become a standard tool during bypass surgery to catch and fix blood flow problems immediately, potentially reducing complications.
What could go wrong
This is a single-center trial with 380 patients, so results may not apply to all hospitals. The ultrasound adds time and training, and its benefit over standard surgical judgment is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, 210008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.